64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions
Showing 73 publications
Abstract28 Oct 2026 · ERS Congress 2026
Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.
Topics: COPDExacerbations
Abstract28 Oct 2026 · ERS Congress 2026
A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.
Topics: Chronic coughTrial endpoints & variability
Peer-reviewed1 Oct 2026 · PLOS Global Public Health
Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed15 Sep 2026 · Scientific Reports
Mechanistic and clinical study linking heatwave-level air dryness to cough hypersensitivity, with a placebo-controlled pilot trial showing reduced cough bouts after alkaline divalent salt aerosols, measured with Hyfe continuous cough monitoring.
Topics: Chronic coughTreatment response
Abstract20 Aug 2026 · ERS Cough Conference 2026
Pilot study in cough-predominant difficult-to-treat and severe asthma using eight weeks of Hyfe continuous monitoring, showing highly variable cough not captured by asthma questionnaires.
Topics: AsthmaTrial endpoints & variabilityExacerbations
Peer-reviewed27 Jun 2026 · Lung
Scoping review of 50 validation studies of ambulatory cough monitoring systems, showing wide variation in reference standards, cough definitions and outcome metrics, and calling for standardized validation protocols.
Topics: Validation
Abstract24 Jun 2026 · World Bronchiectasis Conference 2026
Real-world validation of Hyfe’s fully on-device cough monitoring smartwatch against expert human annotation in 31 adults, showing high agreement for hourly and daily cough counts.
Topics: Chronic coughValidation
Peer-reviewed22 Jun 2026 · ERJ Open Research
First study to assess the antitussive effect of a drug using continuous cough monitoring, tracking patients on a Hyfe-enabled smartwatch for five weeks around the start of azithromycin.
Topics: Chronic coughCOPDIPFAsthmaTreatment response
Abstract18 Jun 2026 · ATS 2026
Interim results from the first continuous, 24/7 characterization of cough in COPD, showing excellent adherence to wearable monitoring and early signs of cough changes before exacerbations.
Topics: COPDExacerbations
Abstract18 Jun 2026 · ATS 2026
Continuous monitoring in stable refractory/unexplained chronic cough shows high day-to-day variability and poor agreement between daily VAS scores and objective cough counts, with direct implications for trial enrollment and endpoints.
Topics: Chronic coughTrial endpoints & variability
Peer-reviewed26 May 2026 · Scientific Reports
External validation of the CODA TB DREAM Challenge cough-only models in an independent Peruvian cohort recorded with the Hyfe Research app, showing reduced performance outside the original training populations.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed29 Dec 2025 · ERJ Open Research
Pilot cohort study of behavioural cough suppression therapy delivered to small telehealth groups with rolling enrolment, with exploratory objective cough monitoring using Hyfe’s CoughPro app.
Topics: Chronic coughDigital TherapeuticsTreatment response
Abstract4 Dec 2025 · American Cough Conference 2025
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
Topics: Chronic coughDigital Therapeutics
Peer-reviewed30 Nov 2025 · Journal of Thoracic Disease
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Topics: Trial endpoints & variabilityValidation
Abstract18 Nov 2025 · ERS Congress 2025
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
Topics: Chronic coughCOPDIPFTreatment response
Abstract18 Nov 2025 · ERS Congress 2025
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Topics: Chronic coughCOPDIPFTreatment response
Abstract18 Nov 2025 · ERS Congress 2025
Independent ERS 2025 pilot uses the Hyfe Cough Monitoring System to track inhaled antibiotic tolerance in bronchiectasis, flagging adverse responses early.
Topics: BronchiectasisTreatment response
Abstract18 Nov 2025 · ERS Congress 2025
This ERS 2025 abstract from Hyfe's R&D team validates the wear-detection algorithm built into the Hyfe CoughMonitor smartwatch against participant-reported wear status across 418 person-hours of data in ten participants.
Topics: Validation
Abstract18 Nov 2025 · ERS Congress 2025
Hyfe ERS 2025 abstract presents evidence for a 7-day cough monitoring standard, replacing 24-hour windows long used in respiratory clinical research.
Topics: Chronic coughTrial endpoints & variability
Research memo11 Nov 2025 · EMJ Respiratory
Authored by Hyfe's R&D team, this review synthesizes work presented at the European Respiratory Society Congress 2025 and argues that objective cough monitoring has crossed a practical threshold, moving from experimental technique to deployable clinical endpoint.
Topics: ValidationTrial endpoints & variability
Abstract21 Oct 2025 · CHEST 2025
Proof-of-concept study of behavioural cough suppression therapy delivered through the CoughPro app, showing a 42% drop in objectively measured cough rate and meaningful quality of life gains in 8 of 10 patients.
Topics: Chronic coughDigital TherapeuticsTreatment response
Peer-reviewed16 Sep 2025 · Open Forum Infectious Diseases
Topics: TuberculosisScreening & diagnosis
Peer-reviewed4 Sep 2025 · American Journal of Speech-Language Pathology
This randomized controlled trial tested whether behavioral cough suppression therapy, a treatment that normally requires in-person visits with a specialized speech-language pathologist, could be delivered entirely online.
Topics: Chronic coughDigital TherapeuticsTreatment response
Peer-reviewed30 Jul 2025 · Therapeutic Advances in Respiratory Disease
A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.
Topics: Chronic coughCOPDIPFTreatment response
Abstract14 May 2025 · ATS 2025
The world’s first DTx for Refractory/Unexplained Chronic Cough (RCC/UCC). What it is? Digitally delivered behavioral cough suppression therapy (BCST), designed for high engagement to promote strong adherence. It includes continuous, passive cough monitoring and biofeedback loop enabling tailored personalization.
Topics: Chronic coughDigital Therapeutics
Abstract14 May 2025 · ATS 2025
This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.
Topics: COPDTreatment response
Abstract14 May 2025 · ATS 2025
A 7-day monitoring duration provides a robust, standardized timeframe for assessing cough frequency in clinical studies, offering a significant improvement over the traditional 24-hour period. This duration captures inter- and intra-individual cough variability.
Topics: Chronic coughTrial endpoints & variability
Abstract14 May 2025 · ATS 2025
Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.
Topics: Chronic coughTrial endpoints & variability
Peer-reviewed6 Jan 2025 · Scientific Reports
This analysis of cough events demonstrated that the Hyfe CoughMonitor smartwatch, compared to a human listener, accurately detects coughs, with high sensitivity and a low false positive rate. Future studies should focus on its potential role in the management of patients with cough in clinical practice.
Topics: Validation
Peer-reviewed18 Oct 2024 · Scientific Data
The article presents a dataset of 733,756 cough sounds from 2,143 patients across 7 countries, accompanied by accurate demographic, clinical, and microbiological diagnostic annotations. It was collected using an early version of Hyfe’s research application, specifically designed to capture cough audio.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed8 Oct 2024 · ERJ Open Research
This is an exploratory, single-blind, nasal saline-controlled study involving 12 patients with refractory chronic cough, designed to examine the cough suppression efficacy of alkaline salts, monitored objectively with the previous version of the Hyfe CoughMonitor Suite.
Topics: Chronic coughTreatment response
Abstract1 Oct 2024 · ERS Congress 2024
This pilot work clarifies a methodology for quantifying this phenomenon and provides preliminary evidence that non-user coughs have a negligible effect on the cough estimates of the Hyfe Cough Monitor Watch in real-world settings.
Topics: Validation
Abstract1 Oct 2024 · ERS Congress 2024
A single-blinded study in 12 chronic cough patients evaluated the cough-suppression efficacy of nasally delivered SC001 (pH 8 or 9) versus saline. Using Hyfe CoughMonitor, patients were monitored over three weeks. Results suggest alkaline (pH 9) SC001 aerosol shows promise for refractory chronic cough treatment.
Topics: Chronic coughTreatment response
Abstract1 Oct 2024 · ERS Congress 2024
A 30-day study of 12 chronic cough patients found no correlation between daily cough counts (median: 93/day) measured by the Hyfe CoughMonitor and symptom severity assessed via the Cough VAS. Further research is needed to identify better endpoints for evaluating chronic cough treatments.
Topics: Chronic coughTrial endpoints & variability
Abstract1 Oct 2024 · ERS Congress 2024
Coughing frequencies vary significantly between and within individuals, for those with a cough frequency of >5 coughs/h. One 24-hour measurement of cough does not reliably reflect long-term trends in up to half of those with persistent cough. This work provides methodological direction for subsequent definitive studies
Topics: Chronic coughTrial endpoints & variability
Abstract1 Oct 2024 · ERS Congress 2024
The Hyfe Cough Monitor System accurately monitors coughing in problematic coughers as they go about their usual daily activities. The ability to continually and passively monitor cough has the potential to improve patient care, cough research and drug development.
Topics: Validation
Peer-reviewed19 Sep 2024 · ERJ Open Research
An earlier version of Hyfe’s cough monitoring technology was used to monitor cough for 6 months in this study with patients with pulmonary tuberculosis. Community-based continuous cough monitoring for pulmonary tuberculosis is feasible in low-resource settings.
Topics: TuberculosisTreatment response
Peer-reviewed1 Aug 2024 · Lung
97 persistent coughers with at least 5 coughs/h were monitored for >20h a day for 30 days in real world environments using Hyfe - 2/3rds of them do not cough like metronomes
Topics: Chronic coughTrial endpoints & variability
Abstract22 May 2024 · ATS 2024
Continuous passive cough monitoring demonstrates the heterogeneous and stochastic pattern of persistent cough and that 24 hour counts often inaccurately reflect longer term cough rates.
Topics: Chronic coughTrial endpoints & variability
Abstract22 May 2024 · ATS 2024
This is the first report demonstrating the feasibility of continual cough monitoring to assess the clinical impact of bronchiectasis therapy. The average rate of cough decreased significantly in all patients, suggesting that the airway clearance protocol at National Jewish is effective in rapidly reducing coughing.
Topics: BronchiectasisTreatment response
Abstract22 May 2024 · ATS 2024
In this pilot study, we were able to collect coughs in the course of routine patient workflows and demonstrate that AI enabled algorithms are predictive of which individuals are likely to have an abnormal CXR.
Topics: Screening & diagnosis
Abstract22 May 2024 · ATS 2024
Over the 477 hours monitored, 4102 cough-seconds were recorded from the 20 subjects; the CoughMonitor detected 3715 of these (overall sensitivity 90.57%) and had 520 false positives (overall false positive rate of 1.09 false positives per hour).
Topics: Validation
Peer-reviewed27 Feb 2024 · Lung
Hyfe CoughTracker, a smartphone application, was utilized for cough monitoring in this study. This was the first study to characterize patients with refractory / unexplained chronic cough responding to codeine treatment in a real-world patient registry.
Topics: Chronic coughTreatment response
Pre-print13 Feb 2024 · arXiv
This pilot study suggests that the acoustic pattern of a solicited cough can help to identify which patients are most likely to have abnormal chest radiographs. AI-enabled cough classification may become a routine tool used by front line healthcare personnel.
Topics: Screening & diagnosis
Peer-reviewed9 Nov 2023 · BMJ Open Respiratory Research
Study on reliability of human annotators finds high agreement within as well as between annotators. Using cough seconds reduces discrepancies by 50% vs. counting coughs. Also reveals significant differences in the length and frequency of cough sounds between men and women.
Topics: ValidationMethods & statistics
Peer-reviewed13 Oct 2023 · Lung
The substantial day-to-day variability in objective cough frequency highlights the need for continuous monitoring. Grasping the implications of daily cough variability is crucial in both clinical practice and clinical trials.
Topics: Chronic coughTrial endpoints & variability
Research memo19 Sep 2023 · Hyfe
Category-defining system for real-time, accurate cough detection using neural networks, optimized for integration into various devices with limited computational resources. Significant step in healthcare tech, offering enhanced capabilities for cough monitoring in diverse appllications
Topics: Validation
Abstract2 Aug 2023 · American Cough Conference 2023
Assesses the accuracy and reliability of the Hyfe CoughMonitor, with expected high correlation for both cough and cough-seconds. The AI-powered capabilities provide continuous and non-intrusive monitoring, and have the potential to improve patient care, cough research and support drug development.
Topics: Validation
Pre-print10 Jul 2023 · arXiv
Results suggest mobile phone-based applications that integrate clinical symptoms and cough sound analysis could help community health workers and, most importantly, health service programs to improve TB case-finding efforts while reducing costs, which could substantially improve public health.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed1 Mar 2023 · The International Journal of Tuberculosis and Lung Disease
Continuous cough monitoring in a multi-country cohort of people being evaluated for Tuberculosis showed that people with TB cough a lot more often than those with other respiratory conditions. The distinct cough patterns in TB patients could be used for improved diagnosis and treatment response monitoring.
Topics: TuberculosisScreening & diagnosisTreatment response
Research memo1 Mar 2023 · Hyfe
This paper describes a pilot study aimed at quantifying the accuracy of AI enabled cough monitoring. We have established a rigorous methodology for evaluating and reporting results and claims to its performance, making us confident that the current version of Hyfe Cough Monitoring System will achieve clinically meaning
Topics: Validation
Peer-reviewed9 Jan 2023 · Journal of Biomedical Informatics
According to this multi-center study results, patients hospitalized with COVID-19 who coughed 3.4 times per hour or less based on digital cough monitoring faced a greater risk for intubation or death.
Topics: COVID-19 & respiratory infectionsScreening & diagnosis
Abstract30 Oct 2022 · ASTMH Annual Meeting 2022
Malaria patients had an almost two-fold probability to experience more than 10 episodes of cough in 30min than patients with other respiratory diseases. These results stress the importance of respiratory symptoms in malaria patients.
Topics: Other conditionsScreening & diagnosis
Abstract4 Sep 2022 · ERS Congress 2022
This e-poster was presented as an oral presentation at ERS 2022 Congress in Barcelona. Based on our experience and case examples presented - objective cough frequency data has great potential to be a part of remote patient monitoring, smoking cessation and medication adherence, and complement PROs.
Topics: COVID-19 & respiratory infectionsOther conditionsTreatment response
Peer-reviewed16 Aug 2022 · Lung
Cough is one of the most common reasons that individuals seek health care, and yet it is largely unmeasured in clinical medicine and practice.
Topics: Chronic coughMethods & statisticsTrial endpoints & variability
Abstract13 Jul 2022 · London International Cough Symposium 2022
This study with 65 chronic cough patients monitored for more than a week suggests that continuous cough frequency monitoring with Hyfe Cough Tracker is potentially useful and applicable to real-world clinical practice.
Topics: Chronic coughTrial endpoints & variability
Pre-print9 Jul 2022 · medRxiv
Continuous cough monitoring using a smartphone application is feasible in low- and middle-income country settings, as shown in this study with 568 participants with presumptive Tuberculosis that were monitored for cough frequency dynamics for at least 10 days.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed6 Jul 2022 · Communications Medicine
Cough assessment is central to the clinical management of respiratory diseases, including tuberculosis (TB), but strategies to objectively and unobtrusively measure cough are lacking. Validated cough assessment could support public health programs at various stages of the TB care cascade.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed1 Jul 2022 · F1000Research
Hyfe Cough Tracker app showed a very high correlation between the cough rate measured by Hyfe and that of human annotators (Pearson correlation of 0.968).
Topics: Validation
Abstract27 Jun 2022 · CHEST 2022
We have observed how objective cough frequency dynamics motivate smokers to quit smoking. A case of a 71 year-old female with a history of smoking 20-40 cigarettes/day between ages 18 to 36, and from age 67 to present is described.
Topics: Other conditionsTreatment response
Peer-reviewed30 May 2022 · ERJ Open Research
This study followed-up 616 participants and collected >62 000 coughs showed that artificial intelligence systems can detect changes in cough frequency that temporarily correlate with the onset of clinical disease at the individual level.
Topics: COVID-19 & respiratory infectionsSurveillance
Abstract19 May 2022 · ATS Respiratory Innovation Summit 2022
This poster overviews Hyfe's values: insights for patient care, clinical cohort management and a powerful research tool.
Peer-reviewed16 May 2022 · ERJ Open Research
Detecting changes in cough rates is complicated by significant stochastic variability. This study monitored cough continuously in a large cohort, allowing for comparison of cough estimates from different observation periods. Intermittent sampling as 24-hour monitoring can often be misleading.
Topics: Trial endpoints & variabilityMethods & statistics
Peer-reviewed25 Apr 2022 · Asia Pacific Allergy
This publication suggests that continuous cough monitoring can be used in remote patient monitoring, with a case of a patient with Long-COVID presented.
Topics: COVID-19 & respiratory infectionsChronic coughTreatment response
Peer-reviewed22 Apr 2022 · DIGITAL HEALTH
4302 coughs were recorded from 960 participants over 11 weeks, requiring approximately 30s to check-in a participant and collect their cough. This study shows that acoustic screening at scale is possible, easy and quick to implement.
Topics: COVID-19 & respiratory infectionsSurveillance
Peer-reviewed23 Mar 2022 · eBioMedicine
This review summarises key technologies in Tuberculosis triage and confirmation. Technologies such as artificial intelligence-based methods are particularly promising, with Hyfe featured as a potential rapidly scalable, and rapid screening tool for cough sound specimens.
Topics: TuberculosisScreening & diagnosis
Peer-reviewed2 Jul 2021 · BMJ Open
Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain. Real-time tracking of the COVID-19 pandemic and detection of the emergence of novel variants or other respiratory pathogens represent challenges for public health authorities globally..
Topics: COVID-19 & respiratory infectionsSurveillance
Research memo1 May 2021 · Hyfe
We use multiple approaches to evaluate the accuracy of Hyfe’s cough detection algorithms and the performance of its apps in various real-world scenarios. In a clinical context, Hyfe has optimized its apps for high performance in quiet indoor settings, such as a bedroom or hospital room, for any user, and for all...
Topics: Validation
Research memo1 Feb 2021 · Hyfe
Hyfe is designed for individual users. High performance means detecting all coughs from a nearby user and no ambient coughs from others in the distance. To achieve this, Hyfe uses various metrics to sort out the soundscape it is analyzing, filtering to loud noise...
Topics: Validation
Research memo5 Jan 2021 · Hyfe
Cough is a ubiquitous health indicator whose impact is extreme and underappreciated. As an information-rich symptom that is associated with a myriad of diseases, cough is also the ideal clinical endpoint. Yet, cough continues to be assessed mainly through limited subjective methods.
Topics: Trial endpoints & variability
Research memo3 Jan 2021 · Hyfe
Cough is an information-rich and readily monitored syndrome that will pioneer ’smart risk profiling’ systems, prove their value in alleviating the global burden of respiratory disease, and usher in a new era of proactive mobile health.
Topics: Surveillance
Research memo2 Jan 2021 · Hyfe
Hyfe's vision for a healthier world, in which smartphones and acoustic epidemiology identify illness and track health, transforming healthcare systems for good.
Topics: Screening & diagnosisSurveillance
Research memo1 Jan 2021 · Hyfe
Topics: Surveillance